Text Size

Lower Urinary Tract Dysfunction Database

This study is currently recruiting participants.
Verified January 2013 by Balgrist University Hospital
Sponsor:
Information provided by (Responsible Party):
Thomas M Kessler, Balgrist University Hospital
ClinicalTrials.gov Identifier:
NCT01293110
First received: February 9, 2011
Last updated: January 8, 2013
Last verified: January 2013
History of Changes
  Purpose

Patients with neurological disease/injury often suffer from lower urinary tract symptoms, which frequently have a negative impact on the patients' health related quality of life. The prevalence of lower urinary tract dysfunction is high and the treatment is a challenge because available treatments may fail. In this study data of patients with lower urinary tract dysfunction treated at the University of Zürich, are prospectively and systematically collected in a database.


Condition
Neurogenic Bladder
Diseases of the Lower Urinary Tract: General Conditions

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Database of Patients With Lower Urinary Tract Dysfunction Treated at the University of Zürich

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Balgrist University Hospital:

Estimated Enrollment: 3000
Study Start Date: January 2010
Estimated Study Completion Date: January 2016
Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Detailed Description:

Lower urinary tract dysfunction is characterized by detrusor overactivity, detrusor sphincter dyssynergia, voiding dysfunction, stress incontinence, or a combination of these and frequently has a negative impact on the patients' health related quality of life. In addition, the treatment of lower urinary tract dysfunction is a challenge because conventional therapies may fail. Adequate treatment and long-term follow-up of lower urinary tract dysfunction is important to achieve/maintain continence and preserve renal function. Thus, we aim to prospectively collect clinical, video-urodynamic and radiological data of patients with neurogenic lower urinary tract dysfunction treated at the University of Zürich in a database.

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Ages Eligibility: minimum 18 years Genders Eligibility: female and male

Criteria

Inclusion Criteria:

  • patient of Balgrist University Hospital
  • patient of University Hospital Zürich
  • urodynamic examination
  • written informed consent

Exclusion Criteria:

  • no written informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01293110

Contacts
Contact: Thomas M Kessler, MD +41 44 3863845 thomas.kessler@balgrist.ch
Contact: Dorothee Birnböck, MD +41 44 3863721 dbirnboeck@paralab.balgrist.ch

Locations
Switzerland
Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital Recruiting
Zürich, Switzerland, 8008
Contact: Thomas M Kessler, MD     +41 (44) 386 3845     thomas.kessler@balgrist.ch    
Sponsors and Collaborators
Balgrist University Hospital
  More Information

No publications provided

Responsible Party: Thomas M Kessler, executive physician, Balgrist University Hospital
ClinicalTrials.gov Identifier: NCT01293110     History of Changes
Other Study ID Numbers: EK 2010-0207/0
Study First Received: February 9, 2011
Last Updated: January 8, 2013
Health Authority: Switzerland: Ethikkommission

Keywords provided by Balgrist University Hospital:
urodynamics
neurogenic lower urinary tract dysfunction
neurological disease/injury

Additional relevant MeSH terms:
Urinary Bladder, Neurogenic
Urologic Diseases
Neurologic Manifestations
 Nervous System Diseases
Urinary Bladder Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 23, 2013